Stocktoria
Solid Biosciences Inc. SLDB
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-01-26
Solid Biosciences Inc. statistics & valuation
Market cap$914.6M
P / B5.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | — | — | — | -1315.2% | -530.5% |
| FCF margin | — | — | — | -1247.7% | -580.4% |
| Current ratio | 6.14 | 5.20 | 8.94 | 9.76 | 9.43 |
| Revenue growth | — | — | — | -40.6% | — |
Source: SEC EDGAR filings · CIK 0001707502 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.